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Summary 
Optimal induction of clonal expansion by normal CD4 T cells requires a ligand that can engage 
the T cell receptor as well as functionally defined costimulatory activity on the same antigen- 
presenting cell surface. While the presence of effective costimulation induces proliferation, T 
cell receptor ligation in its absence renders T cells inactive or anergic.  The molecular basis of 
this costimulatory activity remains to be defined. Here we describe a monoclonal antibody that 
can block the costimulatory activity of splenic accessory cells. Treatment with this antibody not 
only blocks the proliferation of CD4 T  cells to a T  cell receptor ligand, but also induces T 
cell nonresponsiveness to subsequent stimulation. Sequence analysis of the antigen recognized 
by this antibody indicates  that it recognizes a protein that is identical to heat-stable  antigen. 
Gene transfer experiments directly demonstrate that this protein has costimulatory activity. Thus, 
heat-stable  antigen meets the criteria for a costimulator of T  cell clonal expansion. 
O 
ne of the most prominent features of the adaptive im- 
mune system is the generation of diversity by random 
somatic gene rearrangement (1). The generation of diversity 
provides the receptors needed to recognize novel pathogens. 
However, this diversity creates two problems for the immune 
system. The first problem is self-nonself discrimination. Be- 
cause the repertoire of receptors is somatically generated, each 
clone has to be tested for self-reactivity, and autoreactive clones 
have to be inactivated or eliminated. The second problem 
is the low frequency of specific lymphocytes. As the frequency 
of any  specific clone is  the reciprocal  of the diversity of 
receptors,  the adaptive immune response requires clonal ex- 
pansion of specific lymphocytes. This requirement for clonal 
expansion in adaptive immunity (including autoimmune re- 
sponses) provides the immune system with a crucial control 
point at which these two problems may be solved. 
Many recent experiments have demonstrated that the clonal 
expansion of all lymphocytes requires both receptor ligation 
and the receipt of a poorly defined costimulatory signal(s). 
In the case ofT cells, clonal expansion requires both a specific 
peptide/MHC ligand and costimulatory activity on APCs. 
Early work from Lafferty et al. (2, 3) indicted that treatment 
of APCs with UV light or heat inactivation could destroy 
the immunogenicity of the APC without affecting its anti- 
genicity. They referred  to the activity being destroyed as 
"costimulatory activity" Most importantly, they showed that 
this activity is intrinsic to cells of hemopoietic origin, as deple- 
tion of hemopoietic cells from allografts leads to acceptance 
of the graft and a gradual induction of immune tolerance. 
More recently,  Schwartz and coworkers (4, 5) have used a 
well-defined tissue culture model to demonstrate that fixa- 
tion of APCs leads to clonal anergy in the presence of specific 
peptides. Such treatment does not affect the generation of 
the TCR ligand, so it is postulated that clonal anergy is in- 
duced by engaging the TCK in the absence of costimula- 
tion. More recently, we have demonstrated that engaging the 
TCR of cloned Thl cells in the absence of a costimulatory 
signal leads to the death of Thl effector cells (6).  Finally, 
the finding that stimulation of T cells with the TCR ligand 
alone leads to clonal anergy has been confirmed in transgenic 
mice that express MHC antigens on nonhemopoietic tissues 
such as B cells of the islets of Langerhans (7, 8). Together, 
these studies demonstrate that costimulatory activity on APCs 
plays a key role in determining the consequences of the inter- 
action of the TCR with its ligand. It is therefore of great 
interest to define  molecules on APC that are involved in 
costimulation of T  cells. 
Clonal expansion of T  cells involves the binding of the 
TCR and its coreceptors to a peptide/MHC ligand, mAbs 
to a variety of other T  cell and APC molecules have been 
shown to inhibit T cell proliferation, including lymphocyte 
function-associated molecule 1/intracellular adhesion mole- 
cule 1 (LFA-1/ICAM-1) (9), CD2/LFA3 (10), and CD28/ 
B7BB1 (11-13). Although all of these receptor/ligand pairs 
would be defined as costimulatory, we prefer to divide these 
interactions into two distinguishable sets. mAbs to one set 
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clonal expansion is not critical, as in target cell recognition 
by killer T  cells. Molecules of this class are involved in an- 
tigen recognition by the T cell. mAbs to the other set affect 
only clonal expansion. These recognize what we would call 
costimulators, as they regulate T  cell behavior after an an- 
tigen is recognized. In the presence ofmAbs to such costimula- 
tory molecules, not only would clonal expansion be blocked, 
but also one would expect a state of T  cell inactivation or 
anergy to be induced. By contrast, mAbs that prevent TCR 
signaling should prevent the induction of anergy. This pro- 
vides a test for distinguishing between the two sets of mAbs 
that prevent T  cell clonal expansion. 
In this report, we describe a mAb, 20C9, that blocks clonal 
expansion of normal CD4 T cells. Engagement of the TCR 
in the presence of this mAh leads to functional inactivation 
of T  cells. Thus, this mAb meets the criteria for inhibition 
of the delivery of costimulatory activity by APCs. Expres- 
sion cloning and cDNA sequencing reveal that this mAb recog- 
nizes  the  heat-stable  antigen.  Gene  transfer  experiments 
confirm that heat-stable antigen has a direct costimulatory 
activity for clonal expansion of normal CD4 T  cells. 
Materials and Methods 
Production ofmAbs.  BALB/c ByJ and CBA/CaJ mice, used at 
8-10 wk old, were purchased from The Jackson Laboratory (Bar 
Harbor, ME). Armenian hamsters (Cytogen Research and Devel- 
opment, West Roxbury, MA) were immunized by four consecu- 
tive intraperitoneal injections each of 107 LPS-activated B cells 
from CBA/CaJ mice. The spleen cells were fused to Ag8.653 and 
hybrids selected  in HAT medium. The supernatants were screened 
for their ability to inhibit the proliferation of CD4 T cells purified 
from BALB/cByJ  mice to the anti-CD3 mAb YCD3-1 (14) and 
irradiated LPS-activated syngeneic B cells as described (15). Posi- 
tive clones were subcloned three times, mAbs were purified from 
hybridoma supernatants on a protein G--Sepharose column. 
Expression Cloning of 20C9 cDNA and Generation of CHO Trans- 
fectants.  20C9 cDNA  was cloned as previously described (16). 
Briefly, a cDNA library was prepared from mKNA isolated from 
LPS- and IL-4-activated  BALB/c spleen ceils and inserted into the 
pCDM8 expression vector. The cDNA library was transfected  into 
COS cells by the DEAE-dextran method (16), COS cells were in- 
cubated with 20C9 mAb, and the cells expressing 20C9 protein 
were isolated by panning onto plates coated with goat anti-ham- 
ster IgG (Caltag Laboratories, San Francisco, CA). Episomal  DNA 
was recovered from the adherent cells, amplified  in Escherichia coli, 
and reintroduced into COS cells. After three rounds of transfec- 
tion and panning, plasmid  DNA was prepared from individual  bac- 
terial colonies and transfected into  COS cells. The cell surface 
expression of 20C9 protein was determined by indirect immuno- 
fluorescence. 
cDNA from clone 20C9C7 was transfected  into CHO cells that 
had previously  been transfected with the gene encoding FcKIIB2 
(kind gift of Dr. Ira Mellman, Yale University; 17), according to 
previously described procedures (11). Briefly, a mixture of 10 #g 
of 20C9C7 DNA  and  1  #g  of EBOpLPP  vector carrying  a 
hygromycin-resistance  gene was used to transfect COS cells by 
lipofection. These ceils were then selected with DMEM containing 
0.4 mg/ml of hygromycin and 5% FCS. Positive cells were sorted 
2 wk later in a FACStar Plus  |  cell sorter (Becton Dickinson & 
Co.), and individual clones were obtained by limiting dilution. 
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Assays for Proliferation of CD4 T Cells.  Both normal CD4 T 
cells and cloned Thl ceils were used in this study. Normal CD4 
T cells were prepared from CBA/CaJ and BALB/cByJ  mice as de- 
scribed (15). The Thl clone 5.9 has also been described fully (18). 
B ceUs were prepared from spleen  nonadherent ceils after  two rounds 
of  anti-Thy-1 mAb (HO 13.4.9; reference  19) and complement lysis, 
and were activated with 10 ~tg/ml of LPS (15). These B cells were 
either irradiated (2,000 rad) or fixed with 1% paraformaldehyde 
(15) before being used as accessory  cells. In some experiments, acti- 
vated B ceUs (107/ml) were incubated with 100 #g/ml of mAb for 
i h at 4~  before fixation. Transfectants  of  CHO cells  were treated 
with mitomycin C (100 #g/ml) before use as accessory  cells. Un- 
less specified  in the text, CD4 T cells were purified as previously 
described and incubated with accessory cells and a 1:40 dilution 
of  YCD3-1. Proliferation was determined after 42 h by pulsing the 
culture for 6 h with 1 #Ci/well of [~H]TdR. Results of dupli- 
cate/triplicate  cultures in  which  the  variation was  g20%  are 
reported. 
Cleavage of  Glffosyl-Phosphatidylinositol (GPI)'  Linkage  by 
Phosphoinositol-s~cific  Phospholipase C (PI-PLC) and Flow Cytometry. 
A20 cells (10Vml) in serum-free Click's EHAA medium were in- 
cubated with PI-PLC (152354; ICN Biochemicals,  Cleveland,  OH), 
at a 1:200 dilution at 37~  in a water bath for 1 h. The enzyme 
was washed away with PBS, and the treated and untreated cells 
were stained with 20C9 mAb undiluted hybridoma supernatant 
followed by FITC-labeled goat anti-hamster IgG (mouse and rat 
Ig adsorbed; Cahag Laboratories). Anti-Mac-1 mAb M1/70 (20), 
anti-FcR mAb 2.4G2 (21), and anti-heat-stable antigen mAbs  Jlld 
(22) and M1/69  (23) were also used in  flow cytometry and/ 
or proliferation assays, which  was performed as described pre- 
viously (15). 
Results 
A  mAb that Inhibits  T  Cell Clonal Expansion  by Blocking 
the Delivery of Costimulatory Activity by APC.  To study the 
clonal expansion of normal CD4 T cells, we have used anti- 
CD3 mAb-induced proliferation of CD4 T cells as a model 
system. Our previous work has demonstrated that B cells 
are the major APC for this response  in murine spleen (15). 
Activation with LPS induces costimulatory activity in B cells 
that is resistant to aldehyde fixation. To generate mAbs that 
can block the delivery of this costimulatory signal for T cell 
activation, we immunized hamsters with LPS-activated B cells 
and made hybridomas. Supematants were screened for inhibi- 
tory effects on the proliferation of normal CD4 T  cells to 
anti-CD3 mAb and irradiated, LPS-activated B cells as acces- 
sory cells. The hybridomas that secreted inhibitory mAbs were 
subcloned three times. One of these inhibitory rnAbs, 20C9, 
is characterized here. 20C9 significantly  inhibits the prolifer- 
ation of CD4 T  calls induced by anti-CD3 (Fig.  1 a) or by 
allogeneic LPS-activated B calls (Fig.  1 b). When a cloned 
T  cell is used as a responder, 20C9 blocks proliferation of 
this cloned line to its antigen, OVA (Fig.  1 c).  20C9 also 
inhibits proliferation of total spleen cells to anti-CD3 (see 
Fig. 3 a), indicating that the antibody has a broad spectrum 
1  Abbreviations used in this paper: GPI, glycosyl-phosphatidylinositol;  PI- 
PLC, phosphoinosltol-specific  phospholipase C. 
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Figure 1.  mAb 20C9 inhibits  proliferation  of T cells. 
(a) Proliferation of CD4 T cells to anti-CD3. BALB/c CD4 
T cells (5  x  104/we11) were cultured with 2  x  104 ir- 
radiated, LPS-activated B cells in the presence of anti-CD3 
mAb (YCD3-1,  hybridoma  supernatant;  1:40). Varying 
concentrations  of 20C9 supernatant were added at the be- 
ginning of the culture. (b) Proliferation ofBALB/ByJ  CD4 
T cells to allogenic LPS-actiwted  B cells from CBA/CaJ 
mice. 20C9 mAb (100 #g/ml) was incubated  with LPS- 
activated B cells at 4~  for 1 h, unbound antibody was 
washed away, and the LPS-blasts were fixed with parafor- 
maldehyde before being used as accessory  cells. Data shown 
are the change in cpm, with the proliferation of the CD4 
T cells in the absence of allogeneic cells subtracted.  (c) 
Proliferation of the Thl clone 5.9 (2  x  104/weU)  to OVA 
(100 #g/ml) presented by irradiated  adherent  cells (105/ 
well) from BALB/c mice. 20C9 mAb was added at a 1:2 
dilution of hybridoma  supernatant. 
of inhibitory effects on the clonal expansion of T  cells in- 
duced via the TCR. 
As the assay system contains both T cells and APCs, 20C9 
could have inhibited T cell proliferation by binding to either 
T cells or LPS-activated B cells. To resolve this issue, we in- 
cubated 20C9 with LPS-activated  B cells. After washing away 
unbound 20C9, LPS-activated  B cells were fixed with parafor- 
maldehyde. As shown in Fig. 2 a, preincubation of 20C9 with 
LPS-activated B cells profoundly inhibits the proliferation of 
CD4 T cells induced by anti-CD3. Control experiments in- 
dicate that the functional antibody cannot be eluted from 
the fixed B cells because the antibody-coated cells do not in- 
hibit if fixed LPS-activating B cells are added to the same 
well (data not shown). The activity of 20C9 on the B cells 
is consistent with two-color FACS  |  data, which indicate that 
20C9 binds only to non-T spleen cells (Fig. 2 b). The protein 
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Figure 2.  20C9 mAb inhibits  proliferation  of CD4 T cells by blocking a component on LPS-activated B cells. (a) Preincubating  20C9 mAb with 
LPS-activated B cells is sufficient to inhibit the proliferation  of the CD4 T cells. LPS-activated B cells were incubated  with 20C9  mAb at 4~  for 
1 h, unbound antibodies were washed away, and the cells were fixed with parafotmaldehyde and used as accessory cells in anti-CD3-induced proliferation 
of CD4 T cells. Preincubation  with normal hamster  Ig or anti-CD4S mAb TIB122 has no effect on the function of the LPS-activated B cells in this 
assay (data not shown).  (b) Analysis of the cellular distribution of the 20(29 epitope  on BALB/c ByJ spleen cells double stained with the anti-Thy-1 
mAb Y19 and with 20C9.  (~p) No 20C9 added; (bottom) 20C9 present.  (c) Cleavage with PI-PLC removes the 20C9 epitope from A20 cells as deter- 
mined by FACScan  |  Similar cleavage was found in normal spleen cells (not shown).  (d) 20C9 mAb inhibits the APC function of fixed LPS-activated 
B cells. LPS-activated B cells were fixed with paraformaldehyde  and used as accessory cells in the proliferative response of CD4 T cells from normal 
CBA/CaJ mice to anti-CD3 (YCD3-1;  1:40). 20C9  mAb supernatants  were added at the onset of the culture. 
439  Liu et al. Figure 3.  Inhibition  of anti-CD3 mAb-induced  proliferation  and cluster formation  of spleen cells by various mAbs. Spleen cells (lOS/weU) from 
CBA/CaJ mice were incubated  with a 1:40 dilution  of YCD3-1 together with either anti-LFA-1 mAb M17/5.2, anti-FcR mAb 2.4G2, or 20C9 at 
various concentrations.  Proliferation  of the spleen cells (a) was determined  at 48 h of culture. Clusters (b) were photographed  at 16 h of culture in 
the presence of anti-CD3 alone or with 1 /zg/ml of the inhibitory  mAbs. 
that this antibody recognizes is anchored to the cell mem- 
brane by a GPI linkage, as PI-PLC can specifically cleave the 
20C9 epitope from B cells (Fig. 2 c). Furthermore, this anti- 
body strongly inhibits the accessory  cell function of fixed 
B cells (Fig. 2 d). As paraformaldehyde-faxed B cells are meta- 
bolically inert, it is most likely that 20C9 mAb binds to and 
inhibits the action of a component expressed on LPS-activated 
B cells, which is necessary for proliferation of CD4 T  cells. 
20C9 mAb does not bind to the FcR, as it binds to FcR+ 
A20  cells  and  an  FcR-  variant  equally  well  (data  not 
shown). In addition, 20C9 mAb does not affect the function 
of the FcR. on LPS-activated B cells in anti-CD3-induced ac- 
tivation of cloned T cells (Liu, Y., and C. A. Janeway, manu- 
script submitted for publication). Thus, 20C9 mAb inhibits 
T cell proliferation by a mechanism other than affecting the 
function of the FcR. 
Many mAbs specific for accessory molecules required for 
T cell activation inhibit the formation of T cell APC clusters. 
20C9 inhibits anti-CD3-induced proliferation of spleen cells 
without inhibiting cluster formation induced by anti-CD3 
mAb.  This contrasts with the effects of anti-LFA-1  mAb 
M17/5.2 (20) and anti-FcR mAb 2.4G2 (21), which inhibit 
cluster formation as well as .proliferation.  Anti-LFA-1  mAb 
M17.5.2 and anti-FcR mAb 2.4G2 inhibit spleen prolifera- 
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Figure 5.  20C9C7-cloned cDNA transfers 20C9 reactivity to COS cells. 
COS cells at 50% confluency were transfected with 20C9C7 cDNA by 
the DEAE-dextran method. The COS cell monolayer  was stained with 
20C9 mAb or a control hamster  mAb 30C4.  The cells were harvested 
from the plates, and the cell surface expression of 20C9 protein was ana- 
lyzed by FACScan  | 
Figure 4.  The effect of preculture  of CBA/CaJ spleen cells on subse- 
quent responses to anti-CD3 plus spleen accessory cells. (a) Spleen cells 
were precuhured in the presence or absence of anti-CD3 (1:40 dilution 
of hybridoma  supernatant)  and/or 20C9 mAb (0.5/zg/ml) for 48 h.  (b) 
Spleen calls were treated with anti-CD3 together with 1 #g/ml of either 
anti-LFA-1, anti-FcR, or 20C9  mAb. (c) Spleen cells were treated  with 
either no antibody or anti-LFA-1, anti-FcR, or 20C9 mAbs at  1/zg/ml 
in the absence of anti-CD3 mAb. In all cases, viable cells were isolated 
on lymphocyte separation medium 48 h after initial stimulation and washed 
three times. These calls were then stimulated  with fresh anti-CD3 mAb 
and fresh irradiated  CBA/CaJ spleen cells (105/we11) as APC. Prolifera- 
tion of the pretreated  spleen cells was determined  at 72 h (a) or 48 h (b 
and c) of stimulation. 
tion (Fig. 3 a) as well as cluster formation (Fig. 3 b) induced 
by anti-CD3 mAb; 20C9, on the other hand, inhibits anti- 
CD3-induced proliferation without inhibiting duster forma- 
tion. These results demonstrate that 20C9 mAb can inhibit 
T cell proliferation without affecting T cell/APC adhesion. 
It is worth noting that 20C9 induces a low level of duster 
formation of spleen cells on its own, and that anti-CD3 mAb 
further enhances this cluster formation (data not shown). 
Inhibition of Costimulation by 20C9 mAb Leads to CD4 T 
Cell Unresponsiveness to Subsequent Stimulation with Anti-CD3 
mAb and APCs.  As stated in the introduction, stimulating 
T cells with anti-CD3 in the presence of antibodies that block 
costimulatory activity should lead to functional inactivation 
of T ceils. By contrast, T cells treated with anti-CD3 in the 
presence of mAbs that block TCR recognition should be- 
have like untreated ceUs upon subsequent stimulation.  This 
distinction can be used to divide inhibitory antibodies into 
two groups. To examine whether 20C9 blocked TCK signals 
or costimulatory signals, we restimulated spleen cells recov- 
ered from cultures  stimulated  with anti-CD3 mAb in the 
presence or absence of mAbs that inhibit the proliferation 
of T cells to anti-CD3 (see Fig. 3 a).  As shown in Fig. 4 
a, ceils that had been previously stimulated with anti-CD3 
and APC mount what appears to be a secondary proliferative 
response, a substantial proliferative response being seen with 
very low cell numbers. The low total response may reflect 
the kinetics of this response as the experiment was harvested 
at the time of peak primary proliferation (day 3 of restimula- 
tion). Cells treated with medium alone proliferate wdl, while 
441  Liu et al. cells that were pretreated with anti-CD3 in the presence of 
20C9 mAb make only a marginal proliferative response re- 
quiring very high cell numbers, indicating that the pretreat- 
ment induces functional inactivation of the T cells. The reduc- 
tion in response observed is -o20-fold relative to untreated 
cells. This inactivation requires exposure to anti-CD3 in the 
first culture and was not due to the carry-over of the 20C9 
mAb, because treatment of the cells with 20C9 mAb in the 
absence of anti-CD3 mAb allows a proliferative response in 
the second culture similar to that of untreated cells. These 
data suggest that engaging the TCR in the absence of 20C9 
protein leads to functional inactivation  of the T  cells. 
As seen in Fig. 3 a, mAbs directed at several different cell 
surface  molecules can prevent clonal expansion of CD4 T cells 
induced by anti-CD3 and APCs. To test whether treatment 
with mAbs that interfere with cell adhesion (anti-LFA-1) or 
TCR ligation (anti-FcR) also results in functional inactiva- 
tion of T cells exposed to anti-CD3, we treated spleen cells 
with anti-LFA-1, anti-FcR, and 20C9 mAbs in the presence 
or absence of anti-CD3 mAb. 2 d later, the antibodies were 
washed away and the viable cells were restimulated with anti- 
CD3 in the presence of competent APC. As shown in Fig. 
4 b, cells treated with anti-LFA-1 and anti-FcR mAbs plus 
anti-CD3 generate a vigorous proliferative response upon re- 
stimulation, comparable with that of untreated spleen cells 
(Fig. 4 c), while those pretreated with 20C9 plus anti-CD3 
give a significantly reduced response. As the dose of all the 
mAbs used (1 #g/ml) can almost totally inhibit the primary 
proliferative response of T cells to anti-CD3 (Fig. 3 a), these 
results indicate that anti-CD3 combined with anti-LFA-1 or 
anti-FcR mAb does not induce functional inactivation of the 
T ceils, in contrast to anti-CD3 plus 20C9 mAb, nor do we 
observe the augmented response induced by anti-CD3 alone, 
as seen in Fig. 4 a, in any of these cultures. The inhibition 
observed with 20C9 mAb was not due to carry-over of the 
mAb in the culture, as spleen cells treated with 20C9 in the 
absence of the anti-CD3 mAb mount a normal proliferative 
response in secondary stimulation (Fig. 4 c). Thus, the inac- 
tivation  observed requires both anti-CD3 and the presence 
of blocking concentrations  of 20C9. 
Taken together, the above data indicate that 20C9  anti- 
body blocks clonal expansion of T cells induced by anti-CD3, 
allogeneic LPS-activated  B ceils, and antigen presented by syn- 
geneic spleen cells. As 20C9 does not affect ligand recogni- 
tion by the TCR or cell adhesion,  it is likely to block a 
costimulatory signal. This conclusion  is supported  by the 
finding that exposure of T cells to anti-CD3 in the presence 
of 20C9 leads to functional inactivation  of T  cells. 
Expression Cloning of 20C9 Antigen Reveals Its Identity with 
Heat-stable Antigen,  To clone the gene encoding the 20C9 
antigen, COS cells were transfected with a pCDM8-cDNA 
library prepared from LPS-activated spleen B cells. Positive 
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Figure 6.  20C9, Jlld, and M1/69 all bind 
related epitopes.  (a) 20(29 and M1/69 block the 
binding of  Jlld to spleen cells. (b) M1/69 blocks 
the binding of 20(29 mAb to spleen cells. (c) 
Expression of 20C9 protein on CHO-FcR cells 
transfected  with 20C9C7 cloned cDNA. (d) 
Jlld and M1/69 bind to CHO-FcR cells trans- 
fected with the 20C9/C7 cDNA. 
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by panning for 20C9-positive COS cells. Plasmid DNA pre- 
pared from the fourth cycle of panning was found to transfer 
20C9 reactivity to COS cells. The plasmid DNA was cloned, 
and of 55 clones tested, four transferred 20C9 reactivity to 
COS cells. As shown in Fig. 5, COS cells transfected with 
cDNA from one of those dones (20C9C7) bound 20C9 mAb 
but not 30C4, a control hamster mAb. The sequence of this 
cDNA clone demonstrated that it was the same as that of 
the heat-stable antigen (24).  Furthermore, Jlld binding to 
spleen cells was inhibited by 20C9 and M1/69, while 20C9 
binding to spleen cells was inhibited by M1/69  (Fig.  6,  a 
and b). The identity of these antigens was further confirmed 
by finding that CHO cells transfected with 20C9C7 cDNA 
gain reactivity with 20C9, Jlld,  and M1/69 (Fig.  6, c and 
d).  However, mAbs Jlld and M1/69 were not effective in 
inhibiting T  cell proliferation to anti-CD3 mAb (data not 
shown),  suggesting that  these mAbs differ in either their 
binding sites or affinity for heat-stable antigen. 
Heat-stable Antigen  Can Costimulate  the Clonal Expansion 
ofCD4 T Cells.  We directly assessed the costimulatory poten- 
tial of heat-stable antigen by transfection of 20C9C7 cDNA 
into  FcyRII +  CHO  cells  (Fig.  7  a).  Stable  20C9-FcRII 
CHO cells were compared with untranslated FcRII-CHO 
for their ability to induce proliferation of normal CD4 T 
cells. As shown in Fig. 7 b, cloned 20C9-FcRII-CHO cells 
induce significant proliferation of CD4 T ceils to anti-CD3, 
whereas FcRII-CHO cells induce only marginal responses. 
The proliferation induced by 20C9-FcRII-CHO cells was to- 
tally blocked by 20C9 mAb (Fig.  7 c). 
Discussion 
The role of costimulators in the clonal expansion of T cells 
has been defined primarily by the effect of their absence. The 
lack of costimulation in T  cell responses to ligand leads to 
two distinct phenomena, the lack of clona] expansion and 
the inactivation of T cells in forms such as clonal anergy and 
induced cell death (4-6). The inactivation of T  cells in the 
absence of costimulation suggests that expression of costimula- 
tory molecules on hemopoietic cells but not on most cells 
of other tissues could be critical for self-nonself discrimina- 
tion by mature T cells in the periphery (2, 4, 7, 8). Although 
many molecules have been demonstrated to play a role in T 
cell clonal expansion, it remains to be tested whether inacti- 
vation of T cells can be achieved by stimulation in the pres- 
ence of antibodies that block the activity of any of these mol- 
ecules. As most of the treatments used to destroy costimulatory 
activity have been nonspecific, it is possible that these two 
effects are caused by the functional elimination of different 
molecules. Here we report that treatment with the mAb 20C9 
can inhibit clonal expansion of T cells induced by a variety 
of stimuli, indicating that the protein recognized by 20C9 
plays an important role in clonal expansion of T  cells. Fur- 
thermore, adding 20C9 to cultures of T cells stimulated by 
anti-CD3 and APCs induces nonresponsiveness of T cells to 
further stimulation. These results demonstrate that a single 
molecule is responsible both for clonal expansion and for 
prevention of clonal inactivation of T cells. Thus, the 20C9 
protein fulfills  the criteria for a costimulatory molecule on 
APCs. 
The molecules that mediate cell-cell adhesion have also been 
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block their function can block T cell proliferation, while trans- 
fection of these molecules into fibroblasts can enhance the 
T  cell response to ligand.  As T  cells normally respond to 
peptide/MHC  on the surface of APCs,  cell-cell  contact is 
a prerequisite for TCK engagement. We suggest that it is 
appropriate to differentiate those molecules that are required 
for ligand recognition, that is, delivery of signal one, from 
costimulatory molecules that deliver signal two. Despite their 
similar effects on T  cell proliferation, the distinctive effects 
of anti-LFA-1 and 20C9 on cluster formation and on the in- 
duction of unresponsiveness clearly discriminates these two 
classes of molecules. 
Molecular cloning and partial DNA sequencing reveals that 
the gene encoding the 20C9 protein is identical to the previ- 
ously cloned gene encoding heat-stable antigen. Transfection 
with  cDNA  encoding heat-stable antigen  is  sufficient to 
transfer costimulatory activity to CHO cells, demonstrating 
directly that heat-stable antigen costimulates T cells. It has 
been documented that expression of the heat-stable antigen 
is tightly controlled in immature T  cells and in B cells at 
different functional stages  (25).  The function of this mole- 
cule has remained elusive. We show here that heat-stable an- 
tigen cDNA from activated B cells encodes a costimulatory 
molecule that can participate in clonal expansion of CD4 T 
cells. 
The heat-stable antigen contains a very small peptide core 
with  a large number of potential  N-linked and O-linked 
glycosylation sites. The structural basis of its costimulatory 
activity is at present not understood. It is worth noting that 
the level of 20C9 binding activity does not correlate directly 
with the costimulatory activity of a cell. Normal B cells do 
not have constitutive costimulatory activity (15), yet they bind 
20C9 significantly. This discrepanc.y can be explained at least 
in two ways. First, normal B cells may express an inhibitor 
for the costimulatory activity of the heat-stable antigen, and 
this inhibitor is inactivated during B cell activation. Second, 
the heat-stable antigen may be modified during B cell activa- 
tion. Since different cell types seem to have different glycosy- 
lation patterns of the heat-stable antigen (24), one possibility 
would be that glycosylation regulates the costimulatory ac- 
tivity of the heat-stable antigen. This notion is consistent 
with the earlier findings by Frohman and Cowing (26), who 
showed that treatment with neuraminidase can enhance T 
cell stimulation by B cells. 
Adaptive immune responses by ceUs having clonally dis- 
tributed receptors must discriminate self from nonsdf. Many 
experiments have demonstrated that donal deletion mediated 
by the interaction of immature thymocytes with antigen on 
APCs is a major mechanism for removing from the mature 
repertoire those T cells that recognize ligands borne by APCs 
(27,  28).  This mechanism, however, does not apply to an- 
tigens that are expressed in tissues  but are not present on 
APCs in the thymus (7, 8). Thus, there must be mechanisms 
to ensure self-nonsdf discrimination by mature T ceils in the 
periphery. TCK engagement on mature T  cells leads  to a 
number of different consequences depending on the costimula- 
tory activity of the cells that present antigens (4-6). Self an- 
tigens presented by tissue cells induce immune tolerance by 
inactivating specific T  cells (7, 8),  whereas antigens borne 
by microbes that induce costimulatory activity on APCs in- 
duce potent adaptive immune responses (29, 30). Although 
much data are consistent with the two-signal theory (30-32), 
this hypothesis has  not  been subjected to  a  stringent ex- 
perimental test because the nature of signal two on APCs 
has been obscure. Hopefully, with the identification of co- 
stimulatory molecules such as B7 (11-13) and heat-stable an- 
tigen, the two-signal theory itself can now be directly tested. 
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